跳至主要内容
临床试验/NL-OMON25390
NL-OMON25390招募中不适用

Pharmacokinetics of chemotherapeutic agents in children’s oncology

Princess Maxima Center for pediatric oncology0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Planned to receive carboplatin, cisplatin, cytarabine, dactinomycin, daunorubicin, doxorubicin, etoposide, methotrexate or vincristine intravenously as regular treatment (standard of care);
  • 2.Age =18 years;
  • 3.Informed consent form (ICF) signed prior to participation in the study;
  • 4.A present central line to sample blood for pharmacokinetics

排除标准

  • 1.Down syndrome;
  • 2.For fertile adolescent girls: pregnancy (orally inquired, a test is not necessary);
  • 3.Any other disease/circumstances that may influence the participation of the subject in a negative way

研究者

发起方
Princess Maxima Center for pediatric oncology

相似试验